Which has preferable earnings & valuation, IOF or ZTF?

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.47 £4.28M £4.00 12.75 Zotefoams £176.29M 1.21 £9.80M £44.87 9.67

Is IOF or ZTF more profitable?

Zotefoams has a net margin of 13.88% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.18% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Zotefoams 13.88% 18.18% 5.48%

Does the media favor IOF or ZTF?

In the previous week, Iofina had 2 more articles in the media than Zotefoams. MarketBeat recorded 3 mentions for Iofina and 1 mentions for Zotefoams. Zotefoams' average media sentiment score of 1.84 beat Iofina's score of 0.71 indicating that Zotefoams is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iofina 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zotefoams 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better earnings & valuation, IOF or TET?

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.47 £4.28M £4.00 12.75 Treatt £128.29M 1.40 £11.22M £7.22 42.24

Is IOF or TET more profitable?

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Treatt 3.40% 3.22% 6.72%

Which has preferable earnings and valuation, SYNT or IOF?

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.80B 0.09 -£82.04M -£96.00 N/A Iofina £66.52M 1.47 £4.28M £4.00 12.75

Is SYNT or IOF more profitable?

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -6.81%. Iofina's return on equity of 14.89% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -6.81% -13.27% -0.28% Iofina 11.84% 14.89% 5.18%

Do analysts recommend IOF or HDD?

Iofina currently has a consensus price target of GBX 65, indicating a potential upside of 27.45%. Given Iofina's stronger consensus rating and higher probable upside, equities analysts plainly believe Iofina is more favorable than Hardide. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iofina 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Hardide 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, IOF or HDD?

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.47 £4.28M £4.00 12.75 Hardide £8.02M 9.34 -£1.89M £1.80 52.78

Is IOF or HDD more profitable?

Hardide has a net margin of 15.60% compared to Iofina's net margin of 11.84%. Hardide's return on equity of 32.49% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Hardide 15.60% 32.49% -9.80%

Which has stronger earnings & valuation, IOF or ITX?

Iofina has higher revenue and earnings than Itaconix. Itaconix is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.47 £4.28M £4.00 12.75 Itaconix £10.50M 2.59 -£1.49M -£10.20 N/A

Is IOF or ITX more profitable?

Iofina has a net margin of 11.84% compared to Itaconix's net margin of -13.17%. Iofina's return on equity of 14.89% beat Itaconix's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Itaconix -13.17% -15.66% -9.90%

Iofina (IOF) Competitors

GBX 51 0.00 (0.00%)

As of 12:46 PM Eastern

Compare

IOF vs. ZTF, TET, SYNT, HDD, and ITX

Should you buy Iofina stock or one of its competitors? Iofina's main competitors and comparable companies include Zotefoams (ZTF), Treatt (TET), Synthomer (SYNT), Hardide (HDD), and Itaconix (ITX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "specialty chemicals" industry.

How does Iofina compare to Zotefoams?

Iofina (LON:IOF) and Zotefoams (LON:ZTF) are both small-cap materials companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

Iofina has a beta of 0.883, meaning that its share price is 12% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.243, meaning that its share price is 24% more volatile than the broader market.

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.47	£4.28M	£4.00	12.75
Zotefoams	£176.29M	1.21	£9.80M	£44.87	9.67

Iofina currently has a consensus price target of GBX 65, indicating a potential upside of 27.45%. Zotefoams has a consensus price target of GBX 605, indicating a potential upside of 39.49%. Given Zotefoams' higher possible upside, analysts clearly believe Zotefoams is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

1.5% of Iofina shares are owned by institutional investors. Comparatively, 28.9% of Zotefoams shares are owned by institutional investors. 13.4% of Iofina shares are owned by insiders. Comparatively, 4.5% of Zotefoams shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Zotefoams has a net margin of 13.88% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.18% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Zotefoams	13.88%	18.18%	5.48%

In the previous week, Iofina had 2 more articles in the media than Zotefoams. MarketBeat recorded 3 mentions for Iofina and 1 mentions for Zotefoams. Zotefoams' average media sentiment score of 1.84 beat Iofina's score of 0.71 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Iofina	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zotefoams	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Zotefoams beats Iofina on 11 of the 15 factors compared between the two stocks.

How does Iofina compare to Treatt?

Iofina (LON:IOF) and Treatt (LON:TET) are both small-cap materials companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Iofina has a beta of 0.883, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Treatt has a beta of 0.907, meaning that its stock price is 9% less volatile than the broader market.

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Treatt	3.40%	3.22%	6.72%

1.5% of Iofina shares are held by institutional investors. Comparatively, 17.5% of Treatt shares are held by institutional investors. 13.4% of Iofina shares are held by insiders. Comparatively, 4.1% of Treatt shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Iofina presently has a consensus target price of GBX 65, suggesting a potential upside of 27.45%. Treatt has a consensus target price of GBX 248.33, suggesting a potential downside of 18.58%. Given Iofina's stronger consensus rating and higher possible upside, analysts clearly believe Iofina is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Iofina had 3 more articles in the media than Treatt. MarketBeat recorded 3 mentions for Iofina and 0 mentions for Treatt. Iofina's average media sentiment score of 0.71 beat Treatt's score of 0.00 indicating that Iofina is being referred to more favorably in the media.

Company	Overall Sentiment
Iofina	Positive
Treatt	Neutral

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.47	£4.28M	£4.00	12.75
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24

Summary

Iofina beats Treatt on 8 of the 15 factors compared between the two stocks.

How does Iofina compare to Synthomer?

Synthomer (LON:SYNT) and Iofina (LON:IOF) are both small-cap materials companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

Synthomer has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Iofina has a beta of 0.883, suggesting that its share price is 12% less volatile than the broader market.

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -6.81%. Iofina's return on equity of 14.89% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-6.81%	-13.27%	-0.28%
Iofina	11.84%	14.89%	5.18%

14.9% of Synthomer shares are held by institutional investors. Comparatively, 1.5% of Iofina shares are held by institutional investors. 5.0% of Synthomer shares are held by insiders. Comparatively, 13.4% of Iofina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Iofina had 3 more articles in the media than Synthomer. MarketBeat recorded 3 mentions for Iofina and 0 mentions for Synthomer. Iofina's average media sentiment score of 0.71 beat Synthomer's score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Overall Sentiment
Synthomer	Neutral
Iofina	Positive

Synthomer presently has a consensus price target of GBX 119, indicating a potential upside of 21.43%. Iofina has a consensus price target of GBX 65, indicating a potential upside of 27.45%. Given Iofina's stronger consensus rating and higher probable upside, analysts plainly believe Iofina is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.80B	0.09	-£82.04M	-£96.00	N/A
Iofina	£66.52M	1.47	£4.28M	£4.00	12.75

Summary

Iofina beats Synthomer on 12 of the 15 factors compared between the two stocks.

How does Iofina compare to Hardide?

Iofina (LON:IOF) and Hardide (LON:HDD) are both small-cap materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.47	£4.28M	£4.00	12.75
Hardide	£8.02M	9.34	-£1.89M	£1.80	52.78

Hardide has a net margin of 15.60% compared to Iofina's net margin of 11.84%. Hardide's return on equity of 32.49% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Hardide	15.60%	32.49%	-9.80%

1.5% of Iofina shares are owned by institutional investors. Comparatively, 10.2% of Hardide shares are owned by institutional investors. 13.4% of Iofina shares are owned by company insiders. Comparatively, 65.7% of Hardide shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Iofina currently has a consensus price target of GBX 65, indicating a potential upside of 27.45%. Given Iofina's stronger consensus rating and higher probable upside, equities analysts plainly believe Iofina is more favorable than Hardide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Hardide	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Iofina had 3 more articles in the media than Hardide. MarketBeat recorded 3 mentions for Iofina and 0 mentions for Hardide. Iofina's average media sentiment score of 0.71 beat Hardide's score of 0.00 indicating that Iofina is being referred to more favorably in the media.

Company	Overall Sentiment
Iofina	Positive
Hardide	Neutral

Iofina has a beta of 0.883, indicating that its stock price is 12% less volatile than the broader market. Comparatively, Hardide has a beta of 1.163, indicating that its stock price is 16% more volatile than the broader market.

Summary

Iofina beats Hardide on 9 of the 16 factors compared between the two stocks.

How does Iofina compare to Itaconix?

Iofina (LON:IOF) and Itaconix (LON:ITX) are both small-cap materials companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Iofina has a net margin of 11.84% compared to Itaconix's net margin of -13.17%. Iofina's return on equity of 14.89% beat Itaconix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Itaconix	-13.17%	-15.66%	-9.90%

Iofina has a beta of 0.883, indicating that its share price is 12% less volatile than the broader market. Comparatively, Itaconix has a beta of 1.042, indicating that its share price is 4% more volatile than the broader market.

In the previous week, Iofina had 3 more articles in the media than Itaconix. MarketBeat recorded 3 mentions for Iofina and 0 mentions for Itaconix. Iofina's average media sentiment score of 0.71 beat Itaconix's score of 0.00 indicating that Iofina is being referred to more favorably in the media.

Company	Overall Sentiment
Iofina	Positive
Itaconix	Neutral

Iofina has higher revenue and earnings than Itaconix. Itaconix is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.47	£4.28M	£4.00	12.75
Itaconix	£10.50M	2.59	-£1.49M	-£10.20	N/A

Iofina presently has a consensus target price of GBX 65, indicating a potential upside of 27.45%. Itaconix has a consensus target price of GBX 375, indicating a potential upside of 86.09%. Given Itaconix's higher probable upside, analysts clearly believe Itaconix is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Itaconix	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

1.5% of Iofina shares are owned by institutional investors. Comparatively, 10.9% of Itaconix shares are owned by institutional investors. 13.4% of Iofina shares are owned by insiders. Comparatively, 77.5% of Itaconix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Iofina beats Itaconix on 9 of the 14 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IOF vs. The Competition

Export

Metric	Iofina	Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£97.85M	£11.65B	£5.15B	£2.92B
Dividend Yield	2.88%	2.84%	4.68%	6.17%
P/E Ratio	12.75	40.36	26.62	367.62
Price / Sales	1.47	52.86	4,760.35	83,465.25
Price / Cash	7.96	15.27	24.71	27.89
Price / Book	2.27	3.51	9.19	7.11
Net Income	£4.28M	£222.56M	£154.52M	£5.89B
7 Day Performance	-3.77%	0.35%	4.91%	0.51%
1 Month Performance	-12.97%	3.25%	13.20%	3.12%
1 Year Performance	104.00%	19.99%	46.29%	22.15%

Iofina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IOF Iofina	3.8112 of 5 stars	GBX 51 flat	GBX 65 +27.5%	+104.0%	£97.85M	£66.52M	12.75	95	News Coverage
ZTF Zotefoams	4.7008 of 5 stars	GBX 435 flat	GBX 605 +39.1%	+3.6%	£214.47M	£176.29M	9.69	549	Positive News High Trading Volume
TET Treatt	N/A	GBX 305 flat	GBX 248.33 -18.6%	N/A	£180.06M	£128.29M	42.24	350
SYNT Synthomer	N/A	GBX 100 -0.6%	GBX 119 +19.0%	+51.5%	£164.93M	£1.80B	N/A	4,200
HDD Hardide	N/A	GBX 96.25 +4.6%	N/A	+1,183.3%	£72.51M	£8.02M	53.47	46

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IOF) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Iofina (IOF) Competitors